课题基金 / 基金详情

The Role of Hippo Pathway in Liver Regeneration

The Role of Hippo Pathway in Liver Regeneration
Hippo 通路在肝脏再生中的作用
批准号:
8281684
负责人:
ROBERT A. ANDERS
金额:
$34.16万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-06-10 至 2013-05-31

项目摘要

项目成果

ROBERT A. ANDERS的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):肝脏疾病是美国十大死亡原因之一。肝脏非凡的再生能力对于理解导致发育缺陷、急性和慢性肝病以及肝癌发生的机制至关重要。在防止肝细胞凋亡的同时刺激肝细胞增殖对肝脏的再生过程至关重要。最近我们发现一种肿瘤抑制通路对肝细胞分裂和死亡有强有力的影响。我们的长期目标是确定健康和疾病中肝脏再生的细胞机制,并将这些发现应用于开发改进的肝脏疾病治疗方法。为此,我们有独特的能力来解决这一应用的目标,即揭示导致新型肿瘤抑制因子对肝脏产生深远影响的机制。本研究的中心假设是:肿瘤抑制因子通过控制肝细胞生长因子通路来控制肝脏大小。在研究结束时,我们将更好地了解肝细胞的生长和死亡。这将有助于开发许多肝脏疾病的治疗方法,如肝移植、肝硬化、急性和慢性肝炎。
英文摘要
DESCRIPTION (provided by applicant): Liver diseases are among the 10 leading causes of death in the United States. The liver's extraordinary regenerative capacity is critical to understanding the mechanisms leading to developmental defects, acute and chronic liver diseases, and liver carcinogenesis. Stimulation of hepatocyte proliferation while preventing apoptosis is essential to the liver's regenerative process. Recently we uncovered a tumor suppressor pathway has potent effects upon liver cell division and death. Our long range goal is to define the cellular mechanisms underlying liver regeneration in health and disease and to apply these findings to developing improved therapies for liver disease. To that end, we are uniquely capable to address the objectives of this application, which are to uncover the mechanism that leads to the novel tumor suppressors' profound effects upon the liver. The central hypothesis of this proposal is that: The tumor suppressor controls liver celgrowth factor pathway in controlling liver size. At the end of the study we will better understand the growth and death of liver cells. This will help develop treatment for many liver diseases such as liver transplantation, cirrhosis, acute and chronic hepatitis. Project Narrative: The objectives of this study are to uncover a newly recognized very potent molecular system that controls the growth and death of the liver cells. Unlocking how this pathway works will help develop treatment for many liver diseases such as liver transplantation, cirrhosis, acute and chronic hepatitis.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
Co-existence of Sarcina Organisms and Helicobacter pylori Gastritis/Duodenitis in Pediatric Siblings.
儿科兄弟姐妹中八叠球菌微生物和幽门螺杆菌胃炎/十二指肠炎的共存。
DOI: --
发表时间: 2013
期刊: Journal of clinical & anatomic pathology (JCAP)
影响因子: --
作者: [Sauter,JenniferL, Nayar,SureshK, Anders,PaigeD, D'Amico,Michael, Butnor,KellyJ, Wilcox,RebeccaL]
通讯作者: Wilcox,RebeccaL
Hypoxia inducible factor 2 alpha inhibits hepatocellular carcinoma growth through the transcription factor dimerization partner 3/ E2F transcription factor 1-dependent apoptotic pathway.
缺氧诱导因子 2 α 通过转录因子二聚化伴侣 3/E2F 转录因子 1 依赖性细胞凋亡途径抑制肝细胞癌生长。
DOI: 10.1002/hep.26188
发表时间: 2013-03
期刊: HEPATOLOGY
影响因子: 13.5
作者: [Sun, Hai-Xiang, Xu, Yang, Yang, Xin-Rong, Wang, Wei-Min, Bai, Haibo, Shi, Ruo-Yu, Nayar, Suresh K., Devbhandari, Ranjan P., He, Yi-zhou, Zhu, Qin-Feng, Sun, Yun-Fan, Hu, Bo, Khan, Mehtab, Anders, Robert A., Fan, Jia]
通讯作者: Fan, Jia
DOI: 10.1016/j.devcel.2010.06.015
发表时间: 2010-07-20
期刊: DEVELOPMENTAL CELL
影响因子: 11.8
作者: [Zhang, Nailing, Bai, Haibo, David, Karen K., Dong, Jixin, Zheng, Yonggang, Cai, Jing, Giovannini, Marco, Liu, Pentao, Anders, Robert A., Pan, Duojia]
通讯作者: Pan, Duojia
DOI: 10.1002/hep.25769
发表时间: 2012-09
期刊: HEPATOLOGY
影响因子: 13.5
作者: [Bai, Haibo, Zhang, Nailing, Xu, Yang, Chen, Qian, Khan, Mehtab, Potter, James J., Nayar, Suresh K., Cornish, Toby, Alpini, Gianfranco, Bronk, Steven, Pan, Duojia, Anders, Robert A.]
通讯作者: Anders, Robert A.
共 8 条
    Core D: Digital Pathology and CyTOF
    • 批准号:
      10408089
    • 项目类别:
    • 资助金额:
      $34.28万
    • 财政年份:
      2021
    • 负责人:
      ROBERT A. ANDERS
    • 依托单位:
    Core D: Digital Pathology and CyTOF
    • 批准号:
      10661816
    • 项目类别:
    • 资助金额:
      $34.22万
    • 财政年份:
      2021
    • 负责人:
      ROBERT A. ANDERS
    • 依托单位:
    Pathology Core
    • 批准号:
      10093985
    • 项目类别:
    • 资助金额:
      $12.93万
    • 财政年份:
      2019
    • 负责人:
      ROBERT A. ANDERS
    • 依托单位:
    Pathology Core
    • 批准号:
      10356012
    • 项目类别:
    • 资助金额:
      $11.17万
    • 财政年份:
      2019
    • 负责人:
      ROBERT A. ANDERS
    • 依托单位:
    海外基金